How much funding has Rhythm Pharmaceuticals raised?

Rhythm Pharmaceuticals has raised $398.0M in total funding, most recently a Extension Round.

When was Rhythm Pharmaceuticals founded?

Rhythm Pharmaceuticals was founded in 2010.

Where is Rhythm Pharmaceuticals headquartered?

Rhythm Pharmaceuticals is headquartered in Boston, Massachusetts, United States.

What industry is Rhythm Pharmaceuticals in?

Rhythm Pharmaceuticals operates in Healthcare, pharmaceuticals.

How many employees does Rhythm Pharmaceuticals have?

Rhythm Pharmaceuticals has 201-500 employees.

Rhythm Pharmaceuticals

Q: Who are Rhythm Pharmaceuticals's investors?

Rhythm Pharmaceuticals's investors include MPM Capital, New Enterprise Associates, Pfizer Ventures.

IPO

Pioneering a path forward for patients and families.

Public · Boston, United States · Founded 2010 · $398.0M raised

Healthcare

pharmaceuticals

Headquarters: Boston, Massachusetts
Employees: 201–500
Founded: 2010
Business Model: B2B
Website: rhythmtx.com

Total Funding: $398.0M
Last Round: $175.0M Extension RoundJul 2025
Rounds: 4
Type: Public

About

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases. The company develops precision medicines addressing the root cause of diseases driven by the melanocortin-4 receptor (MC4R) pathway, including its lead asset IMCIVREE (setmelanotide) approved for rare genetic obesity disorders such as Bardet-Biedl syndrome and POMC deficiency. Rhythm trades on Nasdaq under the ticker RYTM.

Summary

Rhythm Pharmaceuticals is a Healthcare company based in Boston, United States, founded in 2010. It has raised $398.0M in total across 4 rounds, most recently a $175.0M Extension Round round in Jul 2025. Investors include MPM Capital, New Enterprise Associates and Pfizer Ventures.

LinkedIn X (Twitter)